减少膳食钠的剂量与持续时间对血压水平的影响:随机试验的系统综述与荟萃分析
结果显示减少钠摄入可显著降低收缩压和舒张压,且呈剂量反应关系;老年人、非白人及基线血压较高者降压幅度更大,短期试验低估了钠减少对血压的影响。
要点
- 减少钠摄入可显著降低收缩压和舒张压,且呈剂量反应关系。
- 每减少50 mmol 24小时尿钠,收缩压平均降低1.10 mm Hg。
- 老年人、非白人及基线血压较高者降压幅度更大,短期试验低估效应。
核心结论
- 减少钠摄入降低血压的幅度呈剂量反应关系。
- 老年人、非白人及基线血压较高人群降压幅度更大。
- 短期研究低估了钠减少对血压的影响。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南。
- 检索Ovid MEDLINE、EMBASE、Cochrane CENTRAL及参考文献至2019年1月21日。
- 纳入标准为比较不同钠摄入水平的随机试验,且用24小时尿钠排泄评估摄入。
主要发现
- 减少钠 vs 常规钠:24小时尿钠平均减少130 mmol(95%CI 115–145,P<0.001)。
- 收缩压平均降低4.26 mm Hg(95%CI 3.62–4.89,P<0.001),舒张压降低2.07 mm Hg(95%CI 1.67–2.48,P<0.001)。
- 每减少50 mmol 24小时尿钠,收缩压降低1.10 mm Hg(95%CI 0.66–1.54,P<0.001),舒张压降低0.33 mm Hg(95%CI 0.04–0.63,P=0.03)。
- 高血压和非高血压人群均观察到血压降低。
- 试验持续时间<15天时,每减少50 mmol尿钠收缩压降低1.05 mm Hg(95%CI 0.40–1.70,P=0.002),长于15天的研究为2.13 mm Hg(95%CI 0.85–3.40,P=0.002)。
临床怎么用
- 减少膳食钠可作为降低血压的有效干预措施。
- 对老年人、非白人及基线血压较高者应优先强化限钠。
- 评估限钠降压效果时需考虑干预持续时间,短期试验可能低估效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the dose-response relation between reduction in dietary sodium and blood pressure change and to explore the impact of intervention duration. DESIGN: Systematic review and meta-analysis following PRISMA guidelines. DATA SOURCES: Ovid MEDLINE(R), EMBASE, and Cochrane Central Register of Controlled Trials (Wiley) and reference lists of relevant articles up to 21 January 2019. INCLUSION CRITERIA: Randomised trials comparing different levels of sodium intake undertaken among adult populations with estimates of intake made using 24 hour urinary sodium excretion. DATA EXTRACTION AND ANALYSIS: Two of three reviewers screened the records independently for eligibility. One reviewer extracted all data and the other two reviewed the data for accuracy. Reviewers performed random effects meta-analyses, subgroup analyses, and meta-regression. RESULTS: 133 studies with 12 197 participants were included. The mean reductions (reduced sodium v usual sodium) of 24 hour urinary sodium, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were 130 mmol (95% confidence interval 115 to 145, P<0.001), 4.26 mm Hg (3.62 to 4.89, P<0.001), and 2.07 mm Hg (1.67 to 2.48, P<0.001), respectively. Each 50 mmol reduction in 24 hour sodium excretion was associated with a 1.10 mm Hg (0.66 to 1.54; P<0.001) reduction in SBP and a 0.33 mm Hg (0.04 to 0.63; P=0.03) reduction in DBP. Reductions in blood pressure were observed in diverse population subsets examined, including hypertensive and non-hypertensive individuals. For the same reduction in 24 hour urinary sodium there was greater SBP reduction in older people, non-white populations, and those with higher baseline SBP levels. In trials of less than 15 days' duration, each 50 mmol reduction in 24 hour urinary sodium excretion was associated with a 1.05 mm Hg (0.40 to 1.70; P=0.002) SBP fall, less than half the effect observed in studies of longer duration (2.13 mm Hg; 0.85 to 3.40; P=0.002). Otherwise, there was no association between trial duration and SBP reduction. CONCLUSIONS: The magnitude of blood pressure lowering achieved with sodium reduction showed a dose-response relation and was greater for older populations, non-white populations, and those with higher blood pressure. Short term studies underestimate the effect of sodium reduction on blood pressure. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019140812.
引用
- Huang L, Trieu K, Yoshimura S, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020. PMID: 32094151. doi:10.1136/bmj.m315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。